Search Results 261-270 of 45094 for Two-phase

1. High blood pressure (hypertension) - Diagnosis & treatment - Mayo Clinic

   Blood pressure measurement · Stage 1 hypertension. The top number is between 130 and 139 mm-Hg or the bottom number is between 80 and 89 mm-Hg. · Stage 2 ...

2. Horizon Two Adaptive Platform Study In High Risk Newly Diagnosed Multiple Myeloma - Mayo Clinic

   About this study. The Multiple Myeloma Research Consortium (MMRC) Horizon Two trial is a master protocol, multi-center, phase II randomized adaptive ...

3. A Study Of Durvalumab In Combination With R-CHOP Or Lenalidomide Plus R-CHOP In Previously Untreated High-Risk Diffuse Large B-Cell Lymphoma - Mayo Clinic

   This Phase 2, two-arm, open-label study is designed to evaluate the safety, clinical activity, predictive biomarkers and pharmacokinetics/ pharmacodynamics ...

4. Facilities - Center for Regenerative Biotherapeutics - Mayo Clinic Research

   Two large, modern buildings with a construction crane behind them. One and Two ... Supports manufacturing for phase 1 and 2 trials. Complies with all ...

5. Hematology - Clinical trials

   ... phase II dose (RP2D of APG2575 in combination ... Patients will be randomized 1:1 into the two arms. ... 2-6: 500 mg/m2). Patients randomized to B+R will ...

6. Hilar cholangiocarcinoma - Stages - Mayo Clinic

   How staging works. For hilar cholangiocarcinoma, healthcare professionals often use two different systems to learn about the cancer. Together, these systems ...

7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid) - Mayo Clinic

   Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

8. Vilastobart (XTX101) Monotherapy and Vilastobart and Atezolizumab Combination Therapy in Advanced Solid Tumors - Mayo Clinic

   Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

9. Treatment of recurrent CDI: Examining the efficacy and safety of standardized live biotherapeutics as microbiota restoration therapies - Mayo Clinic

   CDI typically occurs after a two-step process — antibiotics use that disrupts or creates a gap in the microbiome and exposure to C. difficile spores ...

10. A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) - Mayo Clinic

    A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory ...